PARP Inhibitors and Haematological Malignancies—Friend or Foe?

SIMPLE SUMMARY: PARP inhibitors are a class of orally active drugs that kill a range of cancer types by inducing synthetic lethality. The usefulness of PARP inhibitors for the treatment of haematological malignancies has begun to be explored in a variety of both pre-clinical models and human clinica...

Descripción completa

Detalles Bibliográficos
Autores principales: Skelding, Kathryn A., Lincz, Lisa F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582507/
https://www.ncbi.nlm.nih.gov/pubmed/34771492
http://dx.doi.org/10.3390/cancers13215328

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582507/
https://www.ncbi.nlm.nih.gov/pubmed/34771492
http://dx.doi.org/10.3390/cancers13215328

Ejemplares similares